Data / Form D filings / AILERON THERAPEUTICS INC
AILERON THERAPEUTICS INC: Form D filings
AILERON THERAPEUTICS INC, a biotechnology company in Waltham, MA, filed 5 Form D notices with the SEC between 2009 and 2023. The latest, on November 16, 2023, reports $18.3 million sold of a $18.3 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 738 MAIN STREET, UNIT 398, Waltham, MA, 02451
- Phone
- (617) 995-0900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1420565
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | New notice | $18,254,247 | $18,254,247 | 15 | Nov 2, 2023 | sec.gov | |
| Jan 6, 2017 | New notice | $40,000,000 | $30,112,894 | $9,887,106 | 11 | Dec 23, 2016 | sec.gov |
| Oct 29, 2014 | New notice | $32,999,999 | $19,799,999 | $13,200,000 | 13 | Oct 14, 2014 | sec.gov |
| Nov 19, 2013 | New notice | $30,000,000 | $15,000,003 | $14,999,997 | 11 | Nov 5, 2013 | sec.gov |
| Jun 12, 2009 | New notice | $40,150,000 | $28,105,002 | $12,044,998 | 8 | May 29, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan H. Musso | Director | |
| Reinhard J. Ambros | Director | |
| Nolan H. Sigal, M.D., Ph.D. | Director | |
| William H. Fairey | Director | |
| Josef H. von Rickenbach | Director | |
| Manuel Alves-Aivado, M.D., Ph.D. | Executive Officer, Director | |
| Brian L. Windsor, Ph.D. | Executive Officer | |
| Susan L. Drexler | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AILERON THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.